Annuncio pubblicitario
Italia markets open in 56 minutes

  • Dow Jones

    39.806,77
    -196,82 (-0,49%)
     

  • Nasdaq

    16.794,88
    +108,91 (+0,65%)
     

  • Nikkei 225

    38.976,43
    -93,25 (-0,24%)
     

  • EUR/USD

    1,0864
    +0,0002 (+0,02%)
     

  • Bitcoin EUR

    65.537,26
    +3.692,31 (+5,97%)
     

  • CMC Crypto 200

    1.526,60
    +38,05 (+2,56%)
     

  • HANG SENG

    19.269,29
    -366,93 (-1,87%)
     

  • S&P 500

    5.308,13
    +4,86 (+0,09%)
     

Inspire Medical Systems, Inc. to Present at the Wells Fargo 2023 Healthcare Conference

Inspire Medical Systems
·1 minuto per la lettura
Inspire Medical Systems
Inspire Medical Systems

MINNEAPOLIS, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2023 Healthcare Conference on Wednesday, September 6, 2023.

Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

ANNUNCIO PUBBLICITARIO

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443